CLINICAL_TRIALS
trial_result
· 2014-01-22
Clinical Trial Update: Additive Effect of Endonase on Eradication Rate of Second Line Therapy for HP Infection [NA]
Summary
This clinical trial update notes that a study evaluating the additive effect of Endonase on eradication rates for second-line Helicobacter pylori therapy has be…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Chuncheon Sacred Heart Hospital | Conditions: Helicobacter Pylori Infection | NA | Status: TERMINATED